Ultrasound agent ready for sale in Europe:
This article was originally published in Clinica
Executive Summary
Mallinckrodt and Molecular Biosystems will begin selling its ultrasound cardiac imaging agent, Optison, in Germany, Austria and the UK immediately, following European approval. The agent, which is already sold in the US, will be launched in other European countries when pricing approvals are granted.